ConductScience.org, home

Paper36739136

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.

Swen JJ and 41 others. Lancet, 2023. Cited by 452 papers, by iCite.

Cite this record

ConductScience Library. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. Papers, record 36739136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36739136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
PubMed
Journal
Lancet
PubMed
Year
2023
PubMed
Publication types
Randomized Controlled Trial, Multicenter Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
452
iCite
Relative citation ratio, by iCite
58.8
iCite
Revised in PubMed
2026-05-18
PubMed

Authors42

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Swen JJJesse J
2van der Wouden CHCathelijne H
3Manson LELisanne En
4Abdullah-Koolmees HHeshu
5Blagec KKathrin
6Blagus TTanja
7Böhringer SStefan
8Cambon-Thomsen AAnne
9Cecchin EErika
10Cheung KCKa-Chun
11Deneer VHVera Hm
12Dupui MMathilde
13Ingelman-Sundberg MMagnus
14Jonsson SSiv
15Joefield-Roka CCandace
16Just KSKatja S
17Karlsson MOMats O
18Konta LLidija
19Koopmann RRudolf
20Kriek MMarjolein

Source PubMed

See all 42 authorsDownload CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PharmacogeneticsMajor topic
Drug-Related Side Effects and Adverse ReactionsMajor topic
Humans
Male
Female
Genetic Testing
Genotype
Drug Combinations
Treatment Outcome

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/L006758/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03093818PREemptive Pharmacogenomic Testing for Preventing Adverse Drug REactionsDerived from the trialYesClinicalTrials.gov
NCT06907784PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)BackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections8

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Erratum in37633665Department of Error.https://conductscience.org/library/papers/37633665PubMed
Comment in36739126Clinical use of pre-emptive pharmacogenetic programmes.https://conductscience.org/library/papers/36739126PubMed
Comment in37084734Use of a multi-gene pharmacogenetic panel reduces adverse drug effects.https://conductscience.org/library/papers/37084734PubMed
Comment in37270235The PREPARE study: benefits of pharmacogenetic testing are unclear.https://conductscience.org/library/papers/37270235PubMed
Comment in37270236The PREPARE study: benefits of pharmacogenetic testing are unclear.https://conductscience.org/library/papers/37270236PubMed
Comment in37270237The PREPARE study: benefits of pharmacogenetic testing are unclear.https://conductscience.org/library/papers/37270237PubMed
Comment in37276599Genotype-guided drug prescribing vs. usual care reduced clinically relevant adverse drug reactions at 12 wk.https://conductscience.org/library/papers/37276599PubMed
Comment in37337835Temporary Like Achilles: Pre-emptive germline pharmacogenetic testing.https://conductscience.org/library/papers/37337835PubMed

Download CSV of comments and corrections

Cited by338

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 452 citations.

PMIDTitleJournalYearIn PapersSource
42985513Pharmacogenetic testing to improve care in the emergency department.Front Pharmacol2026https://conductscience.org/library/papers/42985513PubMed
42966874Defining Core Functions and Forms for the Implementation of Pharmacogenomics Testing in Primary Care.Clin Transl Sci2026https://conductscience.org/library/papers/42966874PubMed
42942491The LAI-Oral Antipsychotic Efficacy-Effectiveness Paradox in Schizophrenia.Medicina (Kaunas)2026https://conductscience.org/library/papers/42942491PubMed
42938391From Frequencies to Priorities: Interethnic Distribution of Pharmacogenetic Phenotypes as a Basis for Prioritizing Preemptive Testing in Russia's Multiethnic Population.Genes (Basel)2026https://conductscience.org/library/papers/42938391PubMed
42907124Efficacy of Tuina on pain, functional activity, muscle strength and brain activity for patients with knee osteoarthritis in Shanghai: a randomised controlled trial protocol.BMJ Open2026https://conductscience.org/library/papers/42907124PubMed
42898243Liver enzyme elevations during statin-ezetimibe therapy in ABCG2 c.421C>A variant carriers: a case series and narrative review.Front Pharmacol2026https://conductscience.org/library/papers/42898243PubMed
42897167The pharmacogGENEtics in Youth Depression (GENE-YD) study for personalizing antidepressant pharmacotherapy for young Western Australians - A feasibility study.Transl Psychiatry2026https://conductscience.org/library/papers/42897167PubMed
42864318Real-world analysis of genotype-guided treatment for carriers of actionable DPYD and UGT1A1 variants.Pharmacogenomics J2026https://conductscience.org/library/papers/42864318PubMed
42833716PHOENIX: a study protocol for a pilot randomised controlled trial of pre-emptive pharmacogenomic panel testing in acute care settings with health economic evaluations.BMJ Open2026https://conductscience.org/library/papers/42833716PubMed
42824314Population prevalence of high-risk pharmacogenetic configurations in a healthy older Australian reference cohort.Front Pharmacol2026https://conductscience.org/library/papers/42824314PubMed
42820029Dose as a fundamental organizing principle in physiology: Implications for mechanism, disease, and precision medicine.J Precis Med (Amst)2026https://conductscience.org/library/papers/42820029PubMed
42799099Implementation of preemptive pharmacogenetic testing: progress, puzzles and priorities from an implementation science perspective.Front Pharmacol2026https://conductscience.org/library/papers/42799099PubMed
42793009A Strategic Implementation Framework for Integrating Pharmacogenomics (PGx) into Personalized Healthcare in Saudi Arabia.Genes (Basel)2026https://conductscience.org/library/papers/42793009PubMed
42793008Genetic Variants Involved in Metformin Pharmacokinetics in the Chilean Population.Genes (Basel)2026https://conductscience.org/library/papers/42793008PubMed
42756309Vietnamese pharmacogenomic variation in global context: a systematic review and meta-analysis for clinical implementation.Front Pharmacol2026https://conductscience.org/library/papers/42756309PubMed
42744876Patient views on receiving a pharmacogenetic passport - a mixed methods study exploring experiences and use after an opportunistic offer.Eur J Hum Genet2026https://conductscience.org/library/papers/42744876PubMed
42723893Personal Health Data Spaces for precision prevention and continuity of care: integrating genomic, imaging, and clinical data in primary care.Front Med (Lausanne)2026https://conductscience.org/library/papers/42723893PubMed
42718847Individualized pharmacotherapy: background and development.Ann Transl Med2026https://conductscience.org/library/papers/42718847PubMed
42687326A SHAP-Informed Formal Feature Attribution Framework for Drug-Drug Interaction Risk in Large-Scale Claims Data.Clin Transl Sci2026https://conductscience.org/library/papers/42687326PubMed
42677489Dispensing of actionable pharmacogenetic drugs among adults receiving cardiovascular disease medications in the Northern Netherlands: A serial cross-sectional study.Clin Pharmacol Ther2026https://conductscience.org/library/papers/42677489PubMed

See all 338 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36739136

GET https://conductscience.org/api/papers/v1/36739136/authors?page=2